Navigation Links
UT Southwestern, Parkland partner for $6.3 million NCI grant to improve colorectal cancer screenings
Date:10/9/2011

DALLAS Oct. 10, 2011 The National Cancer Institute (NCI) has selected UT Southwestern Medical Center and Parkland Health & Hospital System as a national site to improve screening for colorectal cancer, the nation's No. 3 cancer killer.

The five-year, $6.3 million NCI grant establishes the Parkland-UT Southwestern PROSPR Center as part of a three-site network for colorectal cancer screening. The UT Southwestern-Parkland partnership, which hopes to reach more than 32,000 Dallas County residents age 50 and older, is unique because its screening effort will focus on people who lack insurance or are underinsured.

The NCI's PROSPR designation stands for Population-based Research Optimizing Screening through Personal Regimens. Other colorectal cancer PROSPR sites are in California and Washington. In all, the NCI is establishing nine to 12 PROSPR sites around the country to examine and improve screening processes for colorectal, breast and cervical cancers.

Leading the Dallas core are two UT Southwestern investigators: Dr. Celette Sugg Skinner, associate director of the Harold C. Simmons Cancer Center, and Dr. Ethan Halm, chief of general internal medicine and professor of internal medicine and clinical sciences. Their goal is twofold: to optimize colon cancer screening among Dallas residents and to develop a model for screening that can be used by public hospitals nationwide.

"The earlier we can detect cancers, the better we are able to treat them," said Dr. Skinner, a professor of clinical sciences at UT Southwestern. "Late-stage cancer is harder to treat, and there is no reason why people with less insurance should bear a disproportionate burden of cancer."

There are more than 140,000 new cases of colorectal cancer in the U.S. each year and nearly 50,000 deaths. But the disease, like breast and cervical cancer, can often be cured if caught early.

"Screening for colon cancer has the potential to virtually eliminate colon cancer mortality," said Dr. James K.V. Willson, director of the Simmons Cancer Center.

The project represents a partnership among Parkland, UT Southwestern, the Texas Cancer Registry, the UT School of Public Health in Dallas and the Simmons Cancer Center, which is the only NCI-designated cancer center in North Texas. The joint venture also illustrates the decades-long commitment of UT Southwestern and Parkland to bring together world-renowned research expertise with outstanding clinical care to uninsured and underinsured patients.

Colorectal cancer has higher rates of occurrence and mortality among low-income patients, often because they lack access to proper screening, Dr. Skinner said. The safety net setting of UT Southwestern and Parkland is unique compared to other PROSPR sites, which serve populations that tend to have better insurance coverage.

"There is a known disparity in morbidity related to colorectal cancer that is evident along racial, ethnic and socioeconomic groups," said Dr. John Jay Shannon, Parkland's executive vice president for medical affairs and chief medical officer. "The methodologies we will be exploring in the PROSPR grant are an attempt to apply innovative thinking and behavioral sciences to bridging that disparity."

One of the key factors in securing the NCI grant is Parkland's comprehensive electronic medical records system and its Center for Clinical Innovation, which will serve as the information technology backbone of the collaboration with UT Southwestern, Dr. Halm said.

"With the help of Parkland, we are one of the few places in the country that can conduct this sort of comprehensive cancer screening program for a safety net population," he said.

The grant will help expand and refine three interlocking research projects already under way at UT Southwestern. The first involves a touch-screen computer program used in clinics to ask patients questions in English or Spanish about their personal risk factors and family history, using the responses to generate a personalized screening regimen for colon cancer for each patient.

"People will get personalized recommendations to make sure they get the right care for them," Dr. Halm said. "We especially want to make sure that patients at high risk for colorectal cancer get the enhanced screening they need."

The second project will compare the cost and effectiveness of various outreach strategies aimed at people who are in need of cancer screening. In the third project, investigators will attempt to determine best practices in both the primary care clinics and across the entire Parkland network that most effectively promote screening.

"We have an incredible safety net system that is among the best in the country, and leaders at Parkland who are deeply committed to providing screening and follow-up for people in the community," Dr. Skinner said. "We think the Parkland-UT Southwestern PROSPR Center will make an important dent in colorectal cancer in Dallas County."


'/>"/>

Contact: Jeff Carlton
jeffrey.carlton@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related medicine news :

1. CustomerCentric Selling and Kadient Announce Joint Event in Boston to Launch Strategic Partnership for Sales Enablement and Improvement
2. Diet-to-Go Welcomes 2 Key Philadelphia Fitness Centers as Partners-in-Health
3. Eastern Washington Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
4. Montana Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
5. Central Coast Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign
6. Connecture, Inc. Announces Partnership with MedicareCRM
7. Maximized Living Named as Exclusive Chiropractic Partner of USA Weightlifting
8. DavisPTnetwork Partners with the New York Physical Therapy Association to Provide Online Continuing Education
9. mHealth Alliance Works in Partnership with GSMA to Expand Discussion of Mobile Health at 2010 Mobile World Congress
10. Gael Announce Partner Opportunity in US Healthcare Market
11. SHARECOR Partners With Quantros, Inc. to Facilitate Core Measures and Regulatory Reporting in Louisiana Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... PureLife Dental is pleased to announce that California ... members. As part of the amalgam separator endorsement, all CDA members may purchase an ... off the retail value. This partnership between PureLife and CDA is especially timely as ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... Ulster University, ... June, 2017 from 9 am to 3 pm to present to graduate students exciting ... is an original curriculum project led by The Health Improvement Service of the ...
(Date:6/23/2017)... ... June 23, 2017 , ... All-Star Insurance, a family managed agency ... throughout eastern Texas, is announcing the launch of a new charity drive to benefit ... in the United States reveal that an estimated 252, 710 new cases of invasive ...
(Date:6/22/2017)... , ... June 22, 2017 , ... Branches, Inc. has ... than $245,000 in grant funding to support its programs focused on providing opportunity to ... was awarded a grant by the Foundation of $15,000 to support its , Climb ...
(Date:6/22/2017)... ... ... Groove Ring is excited to announce they've partnered with Olympic runner Jared ... all-purpose rings. Whether you’re an athlete, adventurer, professional, or love to venture the great ... the rock face to the auto shop, Groove Ring is the world's first breathable ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... 14, 2017 The Bio Supply Management Alliance ... of Fremont and the Biomedical Manufacturing Network ... in California by providing a ... and fostering workforce development. The primary focus of this ... start-ups, as well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... June 13, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that the U.S. Food and Drug Administration (FDA) has ... 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter related ... facility is a measure of the progress we have made ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: